Publications
Here you will find a chronological list of the department's publications.
Displaying results 1 to 10 of 168.
Publication
| 2025
Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation.
- Gaebler C, Kor S, Allers K, Perotti M, Mwangi D, Meixenberger K, Hanke K, Trenkner T , Kraus T , Sha Y, Arentowicz C, Odidika S, Grahn N, Scheck R, Perkins N, Pardons M, Igbokwe V, Corman V, Burmeister T, Blau O, Sürücü G, Pruß A, Schneider CG , Klausen G, Sauter J, Klein F, Sander LE, Hofmann J, Vuong L, Bullinger L, Penter L, Gruell H, Reeves DB, Schommers P, Hoelzemer A , Obermeier M, Blau IW, Schneider T, Penack O
-
Nature,
Publication
| 2025
Publication
| 2025
Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovir.
- Zamzamy M, Post S , Ip WH , Hahlin E, Kühn S , Pirosu A , Conze C , Baumdick M , Bunders MJ , Zecher BF , Hoelzemer A , Linder S, Arnberg N, Dobner T , Altfeld M , Schloer S
-
Br J Pharmacol,
Publication
| 2025
The Essential Integration of Sex and Gender in Immunological Research.
- Altfeld M , Consiglio C, Darragh D, Ingersoll M, O'Farrelly C, Pecht T, Shay T, Soares H
-
Immunol Lett,
Publication
| 2025
A transatlantic joint lab model for interdisciplinary research.
- Hoelzemer A , Garcia-Beltran WF
-
Nat Microbiol,
Publication
| 2025
A dual compartment peripheral blood signature of soluble and membrane-bound immune checkpoints predicts outcome in lymphoma patients.
- Gorgulho J, Trenkner T , Kinkel E, Fritzsche B, Kachel P, Peine S, Matschl U , Altfeld M , Huber S, Lohse AW, Alsdorf W, Bokemeyer C, Hoelzemer A , Beltran WG, von Felden J
-
Oncoimmunology,
Publication
| 2025
Corrigendum to "The host cell factor DDX3 mediates sex dimorphism in the IFNα response of plasmacytoid dendritic cells upon TLR activation" [Pharmacol. Res. 216(June) (2025) 107764].
- Schloer S , Hennesen J , Rueschpler L, Zamzamy M, Flomm F, Skenteris NT , Ip WH , Pirosu A , Dobner T , Altfeld M
-
Pharmacol Res,
Publication
| 2025
Publication
| 2025
The imperative for increased investment for an HIV cure.
- van Leeuwen R, Barré-Sinoussi F, Müller-Trutwin M, Sáez-Cirión A, Nijhuis M, Lewin SR, Ndung'u T, Riako-Anam F, Warren M, Sikazwe I, Poniatowski B, Grinsztejn B, Kityo C, Davis M, Søgaard OS, Altfeld M , Martinez-Picado J, Vandekerckhove L, Gramatica A, Sok D, Collins S, Yazdanpanah Y
-
Lancet HIV,
Publication
| 2025
HIV-1 infection of macrophages differentially primes NK-cell cytotoxicity and proinflammatory cytokine production.
- Mensching L, Beiersdorfer M, Schloer S , Köllmann S, Reinsberg F, Padoan B , Fittje P, Trenkner T , Zaayenga A, Martrus G, Almahfoud M, Stürzel CM, Sauter D, Kirchhoff F, Schulze Zur Wiesch J, Altfeld M , Garcia-Beltran WF, Hoelzemer A
-
iScience,
